Supplemental Cash Flow Information

6 Months Ended

Jun. 30, 2022

Supplemental Cash Flow Elements [Abstract]

NOTE 13. Supplemental Cash Flow Information

The following table provides supplemental cash flow information (in thousands):


	Six Months Ended June 30,
	2022		2021
Supplemental cash flow information:
Interest paid	$	1,950	$	2,907
Income taxes paid		566		1,653
Supplemental disclosure of non-cash investing and financing activities:
Right-of-use asset obtained in exchange for new operating lease liability		7,288		861
Reclassification of contingently redeemable common stock in connection with IPO		—		309,500
Issuance of common stock under partner physician group equity agreements upon IPO		—		268,467
Offering costs accrued at end of period		—		558
Non-cash investment in unconsolidated subsidiaries		190		763

The following table summarizes cash, cash equivalents and restricted cash equivalents from continuing operations (in thousands):


	June 30, 2022		December 31, 2021
Cash and cash equivalents	$	668,574	$	1,040,039
Restricted cash and equivalents(1)		15,085		14,781
Cash, cash equivalents and restricted cash equivalents	$	683,659	$	1,054,820

(1)

Restricted cash and equivalents primarily consist of amounts used as collateral to secure letters of credit that the Company is required to maintain pursuant to contracts with payors.